A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks.

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Equipmed USA LLC
Study ID
NCT06602284
Phase
PHASE2/PHASE3
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Acne

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 45 Years
Healthy Volunteers
Accepted

Interventions

  • Dermapen 4™ — COMBINATION_PRODUCT
    Dermapen 4™ conjunction with MG-CLR

Study Details

This study is conducted to check how well the Dermapen 4™ microneedling device works with MG-CLR serum for treating acne over 12 weeks.

Key Dates

Start date
Oct 31, 2024
Status verified
Sep 2024
Primary completion
Mar 31, 2025
Completion
Mar 31, 2025

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: A single arm, full face clinical study.
    Dermapen 4 in conjunction with MG-CLR serum

Primary Outcome Measure

Acne severity [ Time Frame: 13 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Skin Wellness DermatologyBirminghamAlabama35209
Jordan Rubin
[email protected]
205.678.7518
COREY LOUIS HARTMAN

Find similar trials in Birmingham, AL

By research site
Skin Wellness Dermatology· Birmingham, AL

Related Studies